YT-001 (Young Therapeutics)

N/A

Report date: 2024/12/06 11:00:43

Base Information

Drug NameYT-001 (Young Therapeutics)
Drug Alias NameYT-001 (Young Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProtein kinase C epsilon type inhibitors
TargetsProtein kinase C epsilon type
Therapy Area/IndicationsReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYoung Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesYoung Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsReperfusion Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A